Literature DB >> 15905421

Agonist-induced interactions between angiotensin AT1 and epidermal growth factor receptors.

J Alberto Olivares-Reyes1, Bukhtiar H Shah, Judith Hernández-Aranda, Agustín García-Caballero, M Parvaiz Farshori, J Adolfo García-Sáinz, Kevin J Catt.   

Abstract

In rat hepatic C9 cells, angiotensin II (Ang II)-induced activation of angiotensin type 1 (AT(1)) receptors (AT(1)-Rs) stimulates extracellular signal-regulated kinase (ERK) 1/2 phosphorylation via transactivation of the endogenous epidermal growth factor (EGF) receptor (EGF-R) by a protein kinase C (PKC) delta/Src/Pyk2-dependent pathway. This leads to phosphorylation of the EGF-R as well as its subsequent internalization. On the other hand, EGF-induced activation of the EGF-R in C9 cells was found to cause phosphorylation of the AT(1)-R. This was prevented by selective inhibition of the intrinsic tyrosine kinase activity of the EGF-R by AG1478 [4-(3'-chloroanilino)-6,7-dimethoxy-quinazoline] and was reduced by inhibition of PKC and phosphoinositide 3-kinase. EGF-induced AT(1)-R phosphorylation was associated with a decrease in membrane-associated AT(1)-Rs and a reduced inositol phosphate response to Ang II. Agonist activation of endogenous AT(1)-Rs and EGF-Rs induced the formation of a multireceptor complex containing both the AT(1)-R and the transactivated EGF-R. The dependence of these responses on caveolin was indicated by the finding that cholesterol depletion of C9 cells abolished Ang II-induced inositol phosphate production, activation of Akt/PKB and ERK1/2, and AT(1)-R internalization. Confocal microscopy demonstrated that caveolin-1 was endogenously phosphorylated and was distributed on the plasma membrane in patches that undergo redistribution during Ang II stimulation. Agonist-induced phosphorylation and association of caveolin 1 with the AT(1)-R was observed, consistent with a scaffolding role of caveolin during transactivation of the EGF-R by Ang II. The EGF-induced AT(1)-R/caveolin association was abolished by AG1478, suggesting that activation of the EGF-R promotes the association of caveolin and the AT(1)-R.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15905421     DOI: 10.1124/mol.104.010637

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  25 in total

Review 1.  Role of lipid rafts in liver health and disease.

Authors:  Angela Dolganiuc
Journal:  World J Gastroenterol       Date:  2011-05-28       Impact factor: 5.742

Review 2.  Lessons from in vitro studies and a related intracellular angiotensin II transgenic mouse model.

Authors:  Julia L Cook; Richard N Re
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-12-14       Impact factor: 3.619

Review 3.  International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].

Authors:  Sadashiva S Karnik; Hamiyet Unal; Jacqueline R Kemp; Kalyan C Tirupula; Satoru Eguchi; Patrick M L Vanderheyden; Walter G Thomas
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

4.  Cardiac 7-transmembrane-spanning domain receptor portfolios: diversify, diversify, diversify.

Authors:  Stephen B Liggett
Journal:  J Clin Invest       Date:  2006-04       Impact factor: 14.808

Review 5.  Role of Heparin-Binding Epidermal Growth Factor-Like Growth Factor in Oxidative Stress-Associated Metabolic Diseases.

Authors:  Seonwook Kim; Venkateswaran Subramanian; Ahmed Abdel-Latif; Sangderk Lee
Journal:  Metab Syndr Relat Disord       Date:  2020-02-20       Impact factor: 1.894

Review 6.  Crosstalk between the renin-angiotensin system and the advance glycation end product axis in the heart: role of the cardiac fibroblast.

Authors:  Katrina Go Yamazaki; Eileen Gonzalez; Alexander C Zambon
Journal:  J Cardiovasc Transl Res       Date:  2012-09-29       Impact factor: 4.132

Review 7.  Renin-angiotensin system-growth factor cross-talk: a novel mechanism for ureteric bud morphogenesis.

Authors:  Ihor V Yosypiv
Journal:  Pediatr Nephrol       Date:  2008-10-29       Impact factor: 3.714

8.  Caveolin-1 ablation reduces the adverse cardiovascular effects of N-omega-nitro-L-arginine methyl ester and angiotensin II.

Authors:  Luminita H Pojoga; Jose R Romero; Tham M Yao; Paul Loutraris; Vincent Ricchiuti; Patricia Coutinho; Christine Guo; Nathalie Lapointe; James R Stone; Gail K Adler; Gordon H Williams
Journal:  Endocrinology       Date:  2010-01-22       Impact factor: 4.736

9.  Angiotensin-induced EGF receptor transactivation inhibits insulin signaling in C9 hepatic cells.

Authors:  Araceli Arellano-Plancarte; Judith Hernandez-Aranda; Kevin J Catt; J Alberto Olivares-Reyes
Journal:  Biochem Pharmacol       Date:  2009-10-29       Impact factor: 5.858

Review 10.  Pathophysiology of placentation abnormalities in pregnancy-induced hypertension.

Authors:  Mitsuko Furuya; Junji Ishida; Ichiro Aoki; Akiyoshi Fukamizu
Journal:  Vasc Health Risk Manag       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.